These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30930112)

  • 1. Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In Vivo.
    Takai T; Tsujino T; Yoshikawa Y; Inamoto T; Sugito N; Kuranaga Y; Heishima K; Soga T; Hayashi K; Miyata K; Kataoka K; Azuma H; Akao Y
    Mol Ther; 2019 May; 27(5):1017-1027. PubMed ID: 30930112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
    Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1.
    Sugiyama T; Taniguchi K; Matsuhashi N; Tajirika T; Futamura M; Takai T; Akao Y; Yoshida K
    Cancer Sci; 2016 Dec; 107(12):1767-1775. PubMed ID: 27696637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
    Taniguchi K; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakagawa Y; Ito Y; Otsuki Y; Uno B; Uchiyama K; Akao Y
    Cancer Lett; 2015 Jul; 363(1):17-27. PubMed ID: 25818238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells.
    Minami K; Taniguchi K; Sugito N; Kuranaga Y; Inamoto T; Takahara K; Takai T; Yoshikawa Y; Kiyama S; Akao Y; Azuma H
    Oncotarget; 2017 May; 8(20):33064-33077. PubMed ID: 28380435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy.
    Wang X; Li Y; Fan Y; Yu X; Mao X; Jin F
    J Cell Physiol; 2018 Nov; 233(11):8930-8939. PubMed ID: 29856478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of K-Ras signaling networks and increased efficacy of epidermal growth factor receptor inhibitors by a novel synthetic miR-143.
    Akao Y; Kumazaki M; Shinohara H; Sugito N; Kuranaga Y; Tsujino T; Yoshikawa Y; Kitade Y
    Cancer Sci; 2018 May; 109(5):1455-1467. PubMed ID: 29498789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.
    Sugito N; Taniguchi K; Kuranaga Y; Ohishi M; Soga T; Ito Y; Miyachi M; Kikuchi K; Hosoi H; Akao Y
    Nucleic Acid Ther; 2017 Dec; 27(6):365-377. PubMed ID: 28981396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
    Liu R; Li J; Lai Y; Liao Y; Liu R; Qiu W
    Int J Biol Macromol; 2015 Nov; 81():491-7. PubMed ID: 26275461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma.
    Wang Y; Dong D; Jiang S; Zhang E; Zheng W; Mao L; Li W; Zhou J; Fan L; Cheng R; Li Z; Fang Z; Gui Y; Li X
    Cell Physiol Biochem; 2018; 49(5):1755-1765. PubMed ID: 30231239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma.
    Chen X; Shi J; Zhong J; Huang Z; Luo X; Huang Y; Feng S; Shao J; Liu D
    Int J Exp Pathol; 2015 Dec; 96(6):427-32. PubMed ID: 26852690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
    Zhao X; Lu C; Chu W; Zhang B; Zhen Q; Wang R; Zhang Y; Li Z; Lv B; Li H; Liu J
    Tumour Biol; 2017 May; 39(5):1010428317706215. PubMed ID: 28488541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis.
    Zhai W; Ma J; Zhu R; Xu C; Zhang J; Chen Y; Chen Z; Gong D; Zheng J; Chen C; Li S; Li B; Huang Y; Xue W; Zheng J
    Br J Cancer; 2018 Aug; 119(5):591-604. PubMed ID: 30082686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma.
    Chan Y; Yu Y; Wang G; Wang C; Zhang D; Wang X; Wang Z; Jian W; Zhang C
    Med Sci Monit; 2019 Jul; 25():5181-5190. PubMed ID: 31299041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.
    Tokumaru Y; Tajirika T; Sugito N; Kuranaga Y; Shinohara H; Tsujino T; Matsuhashi N; Futamura M; Akao Y; Yoshida K
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors.
    Taniguchi K; Sakai M; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakayama T; Ueda H; Nakagawa Y; Ito Y; Futamura M; Uno B; Otsuki Y; Yoshida K; Uchiyama K; Akao Y
    Oncotarget; 2016 Apr; 7(14):18940-52. PubMed ID: 26980745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
    Sugita S; Enokida H; Yoshino H; Miyamoto K; Yonemori M; Sakaguchi T; Osako Y; Nakagawa M
    Int J Oncol; 2018 Aug; 53(2):725-736. PubMed ID: 29901113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
    Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
    Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras.
    Fang Y; Sun B; Li Z; Chen Z; Xiang J
    Mol Carcinog; 2016 Sep; 55(9):1369-77. PubMed ID: 26333174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141.
    Liu Y; Zhao R; Wei Y; Li M; Wang H; Niu W; Zhou Y; Qiu Y; Fan S; Zhan Y; Xiong W; Zhou Y; Li X; Li Z; Li G; Zhou M
    J Exp Clin Cancer Res; 2018 Mar; 37(1):64. PubMed ID: 29559001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.